phenylmorphan has been researched along with morphine in 3 studies
| Studies (phenylmorphan) | Trials (phenylmorphan) | Recent Studies (post-2010) (phenylmorphan) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 17 | 0 | 10 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | phenylmorphan (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Froimowitz, M | 1 |
| Bergman, J; Bow, EW; Gutman, ES; Imler, GH; Jacobson, AE; Kaska, S; Kerr, AT; Luo, D; Lutz, JA; Paronis, CA; Prisinzano, TE; Rice, KC; Sulima, A | 1 |
| Chambers, DR; Jacobson, AE; Luo, D; Prisinzano, TE; Rice, KC; Sulima, A | 1 |
3 other study(ies) available for phenylmorphan and morphine
| Article | Year |
|---|---|
Preferred conformers for the pharmacologically typical and atypical antipodes of phenylmorphan opiates.
Topics: Molecular Conformation; Morphinans; Morphine; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction | 1984 |
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans.
Topics: Analgesics, Opioid; Morphinans; Morphine; Receptors, Opioid, mu | 2023 |
A MOR Antagonist with High Potency and Antagonist Efficacy among Diastereomeric C9-Alkyl-Substituted
Topics: Analgesics, Opioid; Morphinans; Morphine; Naltrexone; Receptors, Opioid, mu; Structure-Activity Relationship | 2023 |